Within the SSc subgroups, dcSSc patients showed higher TARC levels (634.5 ± 399.1 pg/mL) than the healthy controls (p < 0.0001), while there were no statistically significant differences in TARC levels between the lcSSc patients (357.6. This evidence concerns the gene CCL17 and systemic sclerosis.